Noninvasive Markers Aid Risk Assessment of Prostate Cancer

THURSDAY, May 13, 2021 -- Integration of data from multiple, noninvasive biomarkers can improve risk assessment of patients with a clinical suspicion of prostate cancer prior to an invasive biopsy, according to a study published online April 27 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news